Skip to main content
Equibles

Aberdeen Group plc

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1716774 EDINBURGH, X0
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$54,519,201
+$36,541,917 QoQ
Shares Held
172,480
+91.6% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#29
of 415 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. LGND ranks #10 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 1,096,642 $134,821,167
2 QURE
uniQure N.V.
 2,848,117 $131,184,269
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,601 $104,611,833
4 ARGX
Argenx SE
 83,822 $77,767,536
5 ABVX
Abivax S.A.
 522,025 $69,565,051
6 REGN
Regeneron Pharmaceuticals, Inc.
 101,566 $63,330,462
7 ORKA
Oruka Therapeutics, Inc.
 646,943 $61,569,565
8 INSM
INSMED Inc
 577,437 $61,566,331

All Filings in LGND

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,519,201 172,480
2026-03-31 $17,977,284 90,044
2025-12-31 $22,557,752 119,309
2025-09-30 $33,611,960 189,748
2025-06-30 $26,058,866 229,230
2025-03-31 $22,735,578 216,241
2024-12-31 $18,939,833 176,760
2024-09-30 $24,949,333 249,269
2024-06-30 $22,762,248 270,143
2024-03-31 $20,581,742 281,556
2023-12-31 $20,741,652 290,418
2023-09-30 $19,182,128 320,129
2023-06-30 $28,032,479 388,800
2023-03-31 $20,722,366 281,707
2022-12-31 $20,639,796 308,979
2022-09-30 $38,091,512 442,359
2022-06-30 $38,238,324 428,585
2022-03-31 $37,684,501 335,003
2021-12-31 $55,986,943 362,469
2021-09-30 $49,899,106 358,162
2021-06-30 $53,233,753 405,776
2021-03-31 $26,599,771 174,482
2020-12-31 $36,705,089 369,081
2020-09-30 $18,777,274 196,992